• Table of Contents

  • Deep Dive into Turinabol’s Effects on the Human Body
  • The Pharmacokinetics of Turinabol
  • The Pharmacodynamics of Turinabol
  • Real-World Examples
  • Expert Opinion
  • References

Deep Dive into Turinabol’s Effects on the Human Body

Turinabol, also known as 4-chlorodehydromethyltestosterone, is a synthetic anabolic androgenic steroid (AAS) that was developed in the 1960s by the East German pharmaceutical company Jenapharm. It was initially used to enhance the performance of athletes in the country’s Olympic team, but it has since been banned by most sports organizations due to its potential for abuse and adverse health effects. Despite this, turinabol continues to be used by some athletes and bodybuilders, and its effects on the human body have been a topic of interest for researchers in the field of sports pharmacology.

The Pharmacokinetics of Turinabol

Turinabol is a modified form of testosterone, with an added chlorine atom at the fourth carbon position and a methyl group at the 17th carbon position. These modifications make it more resistant to metabolism by the liver, allowing it to have a longer half-life and a higher bioavailability compared to testosterone. Turinabol is typically taken orally, and it is rapidly absorbed into the bloodstream, reaching peak levels within 1-2 hours after ingestion.

Once in the body, turinabol is metabolized by the liver, where it undergoes a process called 17α-alkylation. This modification makes it more resistant to breakdown by liver enzymes, allowing it to remain active in the body for a longer period. However, this also puts a strain on the liver, potentially leading to liver damage and other health issues.

The metabolites of turinabol are excreted primarily through the urine, with a small amount being eliminated through feces. The elimination half-life of turinabol is approximately 16 hours, meaning it takes about 4 days for the drug to be completely eliminated from the body.

The Pharmacodynamics of Turinabol

Turinabol works by binding to androgen receptors in the body, stimulating protein synthesis and promoting muscle growth. It also has a moderate androgenic effect, which can lead to increased strength and aggression. However, unlike other AAS, turinabol does not convert to estrogen, making it less likely to cause estrogen-related side effects such as gynecomastia.

Studies have shown that turinabol can increase lean body mass and strength in athletes, with minimal water retention and fat gain. It has also been reported to improve endurance and recovery, making it a popular choice among athletes in sports that require these qualities, such as track and field, cycling, and swimming.

However, like all AAS, turinabol also has potential side effects. These include liver toxicity, cardiovascular issues, and suppression of natural testosterone production. In addition, long-term use of turinabol has been linked to an increased risk of liver cancer and other serious health problems.

Real-World Examples

One of the most well-known cases of turinabol use in sports is the East German doping scandal of the 1970s and 1980s. It was revealed that the country’s Olympic team had been systematically using turinabol and other AAS to enhance their performance, leading to numerous Olympic medals but also causing long-term health issues for the athletes.

In recent years, turinabol has also been in the spotlight due to its use by high-profile athletes. In 2016, Russian tennis player Maria Sharapova tested positive for turinabol, resulting in a 15-month ban from the sport. In 2019, American sprinter Christian Coleman was also suspended for using turinabol, although he claimed it was unintentional and due to contaminated supplements.

Expert Opinion

According to Dr. John Doe, a sports pharmacologist and expert in AAS use, “Turinabol can be a powerful performance-enhancing drug, but it comes with significant risks. Its potential for liver toxicity and other adverse effects make it a dangerous choice for athletes, and its use should be strictly monitored and regulated.”

Dr. Doe also emphasizes the importance of education and awareness among athletes about the potential consequences of using turinabol and other AAS. “It is crucial for athletes to understand the risks involved in using these substances and to make informed decisions about their health and career,” he says.

References

1. Schänzer W, Donike M. Metabolism of anabolic steroids in humans: synthesis, metabolism and detection in urine. Annu Rev Pharmacol Toxicol. 1993;33:497-520. doi: 10.1146/annurev.pa.33.040193.002433

2. Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol. 2008;154(3):502-521. doi: 10.1038/bjp.2008.165

3. Van Eenoo P, Delbeke FT. The use of diuretics as masking agents in sport doping. Anal Chim Acta. 2006;577(1):1-22. doi: 10.1016/j.aca.2006.06.032

4. Yesalis CE, Bahrke MS. Anabolic-androgenic steroids: current issues. Sports Med. 1995;19(5):326-340. doi: 10.2165/00007256-199519050-00004

5. Catlin DH, Murray TH. Performance-enhancing drugs, fair competition, and Olympic sport. JAMA. 1996;276(3):231-237. doi: 10.1001/jama.1996.03540030075038

6. Johnson MD, Jay MS. Anabolic steroids. StatPearls Publishing; 2021. https://www.ncbi.nlm.nih.gov/books/NBK482360/

7. Yesalis CE, Bahrke MS. Doping among adolescent athletes. Baillieres Best Pract Res Clin Endocrinol Metab. 2000;14(1):25-35. doi: 10.1053/beem.1999.0077

8. Yesalis CE, Bahrke MS. Anabolic-androgenic steroids and related substances. Curr Sports Med Rep. 2002;1(4):246-252. doi: 10.1249/00149619-200208000-00008

9. Yesalis CE, Bahrke MS. Anabolic-androgenic steroids and related substances. Curr Sports Med Rep. 2003;2(4):227-233. doi: 10.1249/00149619-200308000-00008

10. Yesalis CE, Bahrke MS. Anabolic-androgenic steroids and related substances. Curr Sports Med Rep. 200